Name | Number of supported studies | Average coverage | |
---|---|---|---|
microglial cell | 5 studies | 23% ± 7% |
Insufficient scRNA-seq data for expression of SIGLEC8 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 89% | 272.74 | 2353 / 2642 | 98% | 28.47 | 691 / 705 |
breast | 66% | 62.93 | 303 / 459 | 68% | 3.99 | 757 / 1118 |
adrenal gland | 98% | 330.97 | 253 / 258 | 33% | 1.48 | 75 / 230 |
lung | 91% | 142.98 | 528 / 578 | 39% | 1.88 | 453 / 1155 |
prostate | 89% | 92.42 | 217 / 245 | 25% | 0.88 | 123 / 502 |
stomach | 77% | 58.49 | 276 / 359 | 25% | 1.41 | 72 / 286 |
bladder | 90% | 149.48 | 19 / 21 | 11% | 0.49 | 57 / 504 |
spleen | 95% | 877.37 | 229 / 241 | 0% | 0 | 0 / 0 |
kidney | 17% | 13.04 | 15 / 89 | 74% | 8.31 | 663 / 901 |
lymph node | 0% | 0 | 0 / 0 | 86% | 9.44 | 25 / 29 |
esophagus | 75% | 84.58 | 1090 / 1445 | 9% | 0.46 | 17 / 183 |
intestine | 70% | 146.85 | 679 / 966 | 14% | 0.65 | 76 / 527 |
skin | 37% | 24.04 | 673 / 1809 | 38% | 2.74 | 177 / 472 |
pancreas | 29% | 15.21 | 96 / 328 | 43% | 2.45 | 76 / 178 |
uterus | 56% | 50.62 | 95 / 170 | 13% | 0.64 | 59 / 459 |
adipose | 56% | 40.02 | 676 / 1204 | 0% | 0 | 0 / 0 |
thymus | 18% | 16.64 | 118 / 653 | 25% | 1.35 | 151 / 605 |
liver | 25% | 17.13 | 56 / 226 | 10% | 0.41 | 42 / 406 |
ovary | 13% | 7.70 | 24 / 180 | 22% | 0.99 | 93 / 430 |
tonsil | 0% | 0 | 0 / 0 | 33% | 1.75 | 15 / 45 |
eye | 0% | 0 | 0 / 0 | 31% | 1.99 | 25 / 80 |
blood vessel | 29% | 31.72 | 387 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 28% | 40.42 | 262 / 929 | 0% | 0 | 0 / 0 |
heart | 3% | 1.11 | 27 / 861 | 0% | 0 | 0 / 0 |
muscle | 2% | 0.59 | 15 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0007155 | Biological process | cell adhesion |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0004888 | Molecular function | transmembrane signaling receptor activity |
GO_0030246 | Molecular function | carbohydrate binding |
GO_0005515 | Molecular function | protein binding |
GO_0033691 | Molecular function | sialic acid binding |
Gene name | SIGLEC8 |
Protein name | Sialic acid-binding Ig-like lectin 8 (Siglec-8) (Sialoadhesin family member 2) (SAF-2) Sialic acid binding Ig like lectin 8 |
Synonyms | SAF2 |
Description | FUNCTION: Putative adhesion molecule that mediates sialic-acid dependent binding to red blood cells . Preferentially binds to alpha-2,3-linked sialic acid. Also binds to alpha-2,6-linked sialic acid. The sialic acid recognition site may be masked by cis interactions with sialic acids on the same cell surface . Recognizes simultaneously epitopes having a terminal N-acetylneuraminic acid (sialic acid) and an underlying 6-O-sulfated galactose. Preferentially binds to Gal-6-sulfated sialyl-Lewis X glycan epitopes . . |
Accessions | ENST00000340550.5 [Q9NYZ4-2] ENST00000321424.7 [Q9NYZ4-1] C9JT30 ENST00000430817.5 Q9NYZ4 |